Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI)

[1]  D. Roulin,et al.  Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  S. Mocellin,et al.  Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node , 2008, Annals of Surgical Oncology.

[3]  C. Kaur,et al.  The correlation of regression in primary melanoma with sentinel lymph node status , 2007, Journal of Clinical Pathology.

[4]  G. Botti,et al.  Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous Melanoma , 2007, Annals of Surgical Oncology.

[5]  A. Hauschild,et al.  EORTC 18991: Long-term adjuvant pegylated interferon-alpha2b (PEG-IFN) compared to observation in resected stage III melanoma, final results of a randomized phase III trial , 2007 .

[6]  C. Balch,et al.  Can Completion Lymph Node Dissection Be Avoided for a Positive Sentinel Node in Melanoma? , 2007, Annals of Surgical Oncology.

[7]  A. Chang,et al.  What is a sentinel node? Re‐evaluating the 10% rule for sentinel lymph node biopsy in melanoma , 2007, Journal of surgical oncology.

[8]  S. Mocellin,et al.  Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Katherine S Panageas,et al.  Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Elder,et al.  Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma , 2006, Cancer.

[11]  P. Rutkowski,et al.  Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma , 2006, Annals of surgical oncology.

[12]  N. Cascinelli,et al.  Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Alessandro Ambrosi,et al.  Support Vector Machine Learning Model for the Prediction of Sentinel Node Status in Patients With Cutaneous Melanoma , 2006, Annals of Surgical Oncology.

[14]  D. Elder,et al.  Predictors of Regional Nodal Disease in Patients With Thin Melanomas , 2006, Annals of Surgical Oncology.

[15]  S. Mocellin,et al.  The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  D. Coit,et al.  Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma , 2006, Annals of Surgical Oncology.

[17]  O. Csuka,et al.  Relationship between sentinel lymph node status and regression of primary malignant melanoma , 2005, Melanoma research.

[18]  A. Beauchet,et al.  Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. , 2004, The Lancet. Oncology.

[19]  R. Scolyer,et al.  Sentinel node biopsy for melanoma: Where have we been and where are we going? , 2004, Annals of Surgical Oncology.

[20]  O. Nieweg,et al.  What is a sentinel node and what is a false-negative sentinel node? , 2004, Annals of Surgical Oncology.

[21]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[22]  C. O'brien,et al.  Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy , 2004, Annals of Surgical Oncology.

[23]  W. Greer,et al.  Partial Regression of Primary Cutaneous Melanoma: Is There an Association with Sub-Clinical Sentinel Lymph Node Metastasis? , 2003, The American Journal of dermatopathology.

[24]  M. Walker,et al.  Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. , 2003, Surgery.

[25]  A. Eggermont,et al.  The development of optimal pathological assessment of sentinel lymph nodes for melanoma , 2003, The Journal of pathology.

[26]  Mirto Foletto,et al.  The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients , 2003, Journal of surgical oncology.

[27]  D. Ruiter,et al.  Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group , 2002, The Journal of pathology.

[28]  C. Shea,et al.  Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. , 2002, Archives of dermatology.

[29]  Morton Dl.  Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future. , 2001, Annals of surgical oncology.

[30]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  S. Leong,et al.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. , 1998, Archives of dermatology.

[32]  P. Davidson,et al.  Thin malignant melanomas (< 1.5 mm) with metastasis: a histological study and survival analysis , 1990 .

[33]  S. McCarthy,et al.  Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases , 1989, Histopathology.

[34]  D. Reintgen,et al.  Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk , 1988, Annals of surgery.

[35]  T. K. Das Gupta,et al.  Thin malignant melanomas with regression and metastases. , 1987, Archives of dermatology.

[36]  M. S. Blois,et al.  The regressing thin malignant melanoma. A distinctive lesion with metastatic potential , 1978, Cancer.

[37]  L. Schmidt-Thieme,et al.  Identifying Patients at Risk , 2009 .

[38]  P. G. Lang,et al.  Ultrasound-guided Fine Needle Aspiration Cytology prior to Sentinel Lymph Node Biopsy in Melanoma Patients , 2008 .

[39]  P. G. Lang,et al.  Sentinel-Node Biopsy or Nodal Observation in Melanoma , 2007 .

[40]  K. Busam,et al.  Primary Cutaneous Melanoma with Regression Does not Require a Lower Threshold for Sentinel Lymph Node Biopsy , 2007, Annals of Surgical Oncology.

[41]  V. Sondak,et al.  The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma , 2007, Cancer.

[42]  P. G. Lang,et al.  American Joint Committee on Cancer Clinical Stage as a Selection Criterion for Sentinel Lymph Node Biopsy in Thin Melanoma , 2007 .

[43]  J. Thomas.  Time for comprehensive reporting of MSLT-I. , 2006, The Lancet. Oncology.

[44]  P. G. Lang,et al.  Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial , 2006 .

[45]  R. Scolyer,et al.  Ultrasound Examination of Sentinel Nodes in the Initial Assessment of Patients With Primary Cutaneous Melanoma , 2004, Annals of Surgical Oncology.

[46]  A. Alavi,et al.  Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth Phase , 2000, Annals of Surgical Oncology.

[47]  P. Davidson,et al.  Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. , 1990, Histopathology.